Status
INACTIVE
Global HQ
United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Pre-Seed
- Seed
Industries
- Health Tech
- Biotechnology
About
Medicxi is a prominent venture capital firm specializing in the life sciences sector, with offices strategically located in London, St. Helier (Jersey), and Geneva. The firm is dedicated to identifying and nurturing groundbreaking companies that drive innovation in healthcare and biotechnology. With a robust focus on both venture capital and private equity, Medicxi leverages its extensive industry expertise to provide comprehensive support to its portfolio companies, fostering their growth and advancing transformative solutions in life sciences. Through its commitment to strategic investments, Medicxi aims to create lasting impact and drive progress in improving patient outcomes globally.
Medicxi is a prominent venture capital firm specializing in the life sciences sector, with offices strategically located in London, St. Helier (Jersey), and Geneva. The firm is dedicated to identifying and nurturing groundbreaking companies that drive innovation in healthcare and biotechnology. With a robust focus on both venture capital and private equity, Medicxi leverages its extensive industry expertise to provide comprehensive support to its portfolio companies, fostering their growth and advancing transformative solutions in life sciences. Through its commitment to strategic investments, Medicxi aims to create lasting impact and drive progress in improving patient outcomes globally.
Investment Thesis
Invests in early and midstage life sciences and healthcare companies with transformative potential.
Manager's Experience
Bringing extensive experience in the healthcare sector, the fund manager has actively invested in emerging markets across Europe and North America. With over 50 successful deals, their strategic approach emphasizes a data-driven investment style, focusing on growth-stage companies. Noteworthy exits include several high-profile IPOs, demonstrating a strong track record of value creation. Their thematic investment strategy targets innovative healthcare solutions, aiming to capitalize on market trends and advancements in the industry.